» Articles » PMID: 39578754

Home Physical Therapy Versus Telerehabilitation in Improving Motor Function and Quality of Life in Parkinson's Disease: a Randomized Controlled Trial

Overview
Journal BMC Geriatr
Publisher Biomed Central
Specialty Geriatrics
Date 2024 Nov 23
PMID 39578754
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Over the past few years, the development of telerehabilitation has advanced rapidly. Patients with Parkinson's disease (PwPD) often have difficulty with mobility, making it challenging for them to perform centre-based exercise.This study aims to compare the effectiveness and adherence of home physical therapy (HPT) and telerehabilitation (TR) in mitigating motor symptoms and improving the quality of life in patients with mild to moderate Parkinson's disease.

Methods: This randomized controlled trial included a total of 190 patients who underwent in-person eligibility assessment, with 100 allocated to the HPT group and 90 to the TR group. Both interventions consisted of home-based training sessions lasting 40-60 min and were conducted five times a week for 4 weeks. The primary outcome was the Unified Parkinson's Disease Rating Scale motor section (UPDRS3) score. Secondary outcomes included balance function, assessed using the Berg Balance Scale (BBS); risk of fall, evaluated through the Timed Up-and-Go test (TUG) and the Five Times Sit-to-Stand test (FTSST); gait, measured using the Freezing of Gait Questionnaire (FOGQ) and IDEEA activity monitor; muscle strength, evaluated using the isokinetic dynamometry; motor aspects of experiences of daily living (UPDRS2); and quality of life, assessed by Parkinson's Disease Questionnaire-39 (PDQ-39).

Results: There was a significant difference in the UPDRS3, BBS, TUG, FTSST, FOGQ,step length, step velocity,preswing angle, UPDRS2 and PDQ-39 between baseline and 4 weeks in both groups. The decrease in the UPDRS3 score was significantly greater in the HPT group (-3.38 points) than in the RE group (-1.45 points) in the older age group (P = 0.021), but there was no significant between-group difference in the younger age group (P = 0.416). Similar changes favouring the HPT group were observed in the BBS, TUG, step velocity, and extension average torque. 7 (7%) patients in the HPT group and 12 (13%) patients in the TR group did not complete their daily exercise plan.

Conclusions: Both HPT and TR have demonstrated effectiveness, safety, and feasibility in PwPD. However, the HPT program exhibited greater effectiveness among older patients and higher patient compliance compared to TR.

Trial Registration: Chictr.org.cn, ChiCTR2300071648. Registered on 22 May 2023-retrospectively registered, https://www.chictr.org.cn/showproj.html?proj=196313 .

References
1.
Nocera J, Stegemoller E, Malaty I, Okun M, Marsiske M, Hass C . Using the Timed Up & Go test in a clinical setting to predict falling in Parkinson's disease. Arch Phys Med Rehabil. 2013; 94(7):1300-5. PMC: 4144326. DOI: 10.1016/j.apmr.2013.02.020. View

2.
Jeon Y, Jeong J, Shin S, Song K, Kim Y, Hong K . The effect of age on in-hospital mortality among elderly people who sustained fall-related traumatic brain injuries at home: A retrospective study of a multicenter emergency department-based injury surveillance database. Injury. 2022; 53(10):3276-3281. DOI: 10.1016/j.injury.2022.07.036. View

3.
Yang Y, Fu X, Zhang H, Ouyang G, Lin S . The effect of home-based exercise on motor symptoms, quality of life and functional performance in Parkinson's disease: a systematic review and meta-analysis. BMC Geriatr. 2023; 23(1):873. PMC: 10731835. DOI: 10.1186/s12877-023-04595-6. View

4.
Shulman L, Gruber-Baldini A, Anderson K, Fishman P, Reich S, Weiner W . The clinically important difference on the unified Parkinson's disease rating scale. Arch Neurol. 2010; 67(1):64-70. DOI: 10.1001/archneurol.2009.295. View

5.
Guo Y, Goetz C, Stebbins G, Mestre T, Luo S . Using Movement Disorder Society Unified Parkinson's Disease Rating Scale Parts 2 and 3 Simultaneously: Combining the Patient Voice with Clinician Ratings. Mov Disord. 2023; 38(3):453-463. PMC: 10033355. DOI: 10.1002/mds.29308. View